Food Recalls and Other FDA Administrative Enforcement Actions
Congressional research reportNov 20, 2014
Ask Donna
What actually matters in this document.
Text
Food Recalls and Other FDA Administrative
Enforcement Actions
name redacted
Legislative Attorney
November 20, 2014
Congressional Research Service
7-....
www.crs.gov
R43794
Food Recalls and Other FDA Administrative Enforcement Actions
Summary
The U.S. Food and Drug Administration (FDA) ensures the safety of all food except for meat,
poultry, and certain egg products over which the U.S. Department of Agriculture (USDA) has
regulatory oversight. Under the Federal Food, Drug, and Cosmetic Act (FFDCA), the FDA has
the authority to regulate the manufacturing, processing, and labeling of food with the primary
goal of promoting food safety.
Congress has granted the FDA the authority to take both administrative and judicial enforcement
actions. The agency initiates and carries out administrative enforcement actions while judicial
enforcement actions, including seizures and injunctions, require some type of involvement by the
courts. Additionally, administrative enforcement actions, such as inspections and warning letters,
tend to precede any judicial enforcement action. The Food Safety Modernization Act (FSMA)
expanded the FDA’s enforcement authority with new and broader measures. This report focuses
on the statutory authority and legal issues relating to the following administrative enforcement
actions: inspections, warning letters, recalls, suspension of registration, and administrative
detention.
Inspections: The FDA conducts inspections of regulated facilities in order to oversee a firm’s
compliance with the FFDCA and corresponding regulations. The FFDCA grants the agency with
the enforcement authority to inspect both facilities and records. However, the act narrowly tailors
this authority in order to balance the protection of the facility owners’ Fourth Amendment rights
and the promotion of public health.
Warning Letters: Under the FFDCA, the FDA also has the ability to decline to institute formal
enforcement proceedings for minor violations of the act if the agency believes that it could
adequately serve public interest through written correspondence to violators. These warning
letters give recipient firms an opportunity to take voluntary corrective actions before the FDA
initiates a more formal enforcement action.
Recalls: The recall process permits the FDA to enforce the adulteration and misbranding
provisions of the FFDCA by encouraging industry participants to remove the product and correct
the violation. FDA regulations outline several steps that both the firm and agency must take when
issuing either a voluntary or mandatory recall. FSMA granted the FDA the authority to issue a
mandatory recall. FSMA also established the opportunity for an informal hearing, at which a firm
may dispute these types of recalls, in order to protect the due process rights of the recalling firms.
Suspension of Registration: The FFDCA requires all food facilities to register with the FDA so
that the agency may effectively oversee all areas of food production. If the FDA determines that a
food manufactured, processed, packed, received, or held by a registered facility has a reasonable
probability of causing serious adverse health consequences or death to humans or animals, the
agency may suspend the registration of a facility that created, caused, or was otherwise
responsible. This enforcement authority is intended to permit the agency to determine the location
and source of an outbreak of food-borne illness and thus notify facilities that may be affected
quickly and efficiently.
Administrative Detention: Under the FFDCA, an FDA employee may order the detention of any
article of food that is found during an FDA inspection if the employee has reason to believe that
such article is adulterated or misbranded. Under this administrative detention authority, the FDA
may prevent illegal articles from being moved or consumed until the court grants a seizure order.
Congressional Research Service
Food Recalls and Other FDA Administrative Enforcement Actions
Contents
FDA Enforcement Authority ........................................................................................................... 1
Inspections ....................................................................................................................................... 1
Facilities .................................................................................................................................... 2
Records...................................................................................................................................... 2
Targeting Inspection Resources................................................................................................. 3
Fourth Amendment Constraints ................................................................................................ 3
Warning Letters ............................................................................................................................... 4
Recalls ............................................................................................................................................. 6
Types of Recalls ........................................................................................................................ 6
Voluntary and Mandatory Recalls ....................................................................................... 7
Recall Process ........................................................................................................................... 7
Initiation of the Recall ........................................................................................................ 7
Classification of the Recall ................................................................................................. 8
Notification and Public Warning......................................................................................... 9
Monitoring and Auditing the Recall ................................................................................... 9
Termination of the Recall.................................................................................................. 10
Due Process Protections Within Mandatory Recall Authority ................................................ 10
Suspension of Registration ............................................................................................................ 10
Administrative Detention .............................................................................................................. 12
Contacts
Author Contact Information ........................................................... Error! Bookmark not defined.
Congressional Research Service
Food Recalls and Other FDA Administrative Enforcement Actions
he U.S. Food and Drug Administration (FDA) ensures the safety of all food except for
meat, poultry, and certain egg products over which the U.S. Department of Agriculture
(USDA) has regulatory oversight.1 Under the Federal Food, Drug, and Cosmetic Act
(FFDCA), the FDA has the authority to regulate the manufacturing, processing, and labeling of
food, with the primary goal of promoting food safety.2
T
Congress has granted the FDA with the authority to take both administrative and judicial
enforcement actions. The agency initiates and carries out administrative enforcement actions
while judicial enforcement actions, including seizures and injunctions, require some type of
involvement by the courts. 3 Additionally, administrative enforcement actions, such as inspections
and warning letters, tend to precede any judicial enforcement action. The Food Safety
Modernization Act (FSMA) expanded the FDA’s enforcement authority with new and broader
measures.4 The FDA’s implementation of FSMA and related delays in the rulemaking process, in
addition to general oversight of FSMA’s new food safety provisions, are of continuing interest to
Congress.5 This report focuses on the FDA’s statutory authority to initiate the following
administrative enforcement actions: inspections, warning letters, recalls, suspension of
registration, administrative detention, and related legal issues.
FDA Enforcement Authority
Section 301 of the FFDCA prohibits the violation of any of the substantive provisions of the act
and serves as the basis for the FDA’s enforcement actions.6 Under Section 301, “causing” any of
the prohibited acts as well as the act itself is prohibited. The specific enforcement mechanisms
available to the agency to enforce the FFDCA are found throughout the act. Private citizens do
not have the right to sue to enforce the FFDCA. Section 310(a) states that “all ... proceedings for
the enforcement, or to restrain violations, of this [act] shall be by and in the name of the United
States.”7
Inspections
The FDA conducts inspections of regulated facilities in order to oversee a firm’s compliance with
the FFDCA and corresponding regulations.8 The FFDCA grants the agency with the enforcement
authority to inspect both facilities and records. However, courts have generally held that
inspections properly executed under the FFDCA do not violate the Fourth Amendment rights
against search and seizure of the facility owners.9
1
Memorandum of Understanding with the Department of Agriculture and the Food and Drug Administration, 40 Fed.
Reg. 25079 (June 12, 1975) (agreement concerning related objectives in carrying out the Federal Meat Inspection Act,
Poultry Products Inspection Act, and the Federal Food, Drug, and Cosmetic Act.)
2
21 U.S.C. §301 et seq.
3
See FDA, FDA Compliance and Enforcement Information, available at http://www.fda.gov/AboutFDA/
Transparency/Transparencyinitiative/ucm254426.htm.
4
Food Safety Modernization Act of 2010 (2011) (FSMA), P.L. 111-353, 124 Stat. 3885.
5
See CRS Report R42885, Food Safety Issues for the 113th Congress, by (name redacted), for a discussion on the
current food safety issues of interest to Congress.
6
21 U.S.C. §331.
7
21 U.S.C. §337(a).
8
21 U.S.C. §374.
9
See, e.g., U.S. v. Jamieson-McKames Pharmaceuticals, Inc., 651 F.2d 532, 536-41 (8th Cir. 1981); U.S. v. Del Campo
(continued...)
Congressional Research Service
1
Food Recalls and Other FDA Administrative Enforcement Actions
This section examines the inspection enforcement authority of both facilities and records.
Because of FSMA’s mandate to increase the number of inspections by the FDA, this section also
discusses the tools and methods used by the agency to target inspection resources effectively and
efficiently. The section concludes by analyzing the Fourth Amendment protections embedded
within this particular enforcement authority.
Facilities
The FFDCA authorizes designated FDA employees to enter “at reasonable times and within
reasonable limits and in a reasonable manner” any factory, warehouse, or establishment in which
food is manufactured, processed, packed, or held for introduction into interstate commerce.10
Generally, courts have interpreted “reasonableness” in this context by considering whether the
inspection meets the statutory requirements outlined in Sections 703 and 704 of the FFDCA.11
This inspection authority covers all pertinent equipment, finished and unfinished materials,
containers, and labeling at these locations. The FDA inspector must present the appropriate
credentials and a written notice to the owner, operator, or agent in charge before entering the
facility.12 However, the act does not require the FDA to include the reasons for the inspection in
this notice.13
After the inspection, the FDA employee presents the owner, operator, or agent in charge with a
written report setting forth the conditions or practices observed. This report notes any food that
contains filthy, putrid, or decomposed substances, or whether the food has been prepared, packed,
or held under insanitary conditions, leading to contamination that may be injurious to a
consumer’s health.14 The FDA employee also provides the owner, operator, or agent in charge
with a receipt for any samples obtained during the inspection.15 Refusal to permit an FDA
inspector to duly enter and inspect a regulated facility violates the FFDCA and may lead to the
FDA seeking further judicial enforcement action, such as an inspection warrant issued by a
district court.16
Records
If the FDA reasonably believes that an article of food is likely to be adulterated and presents a
threat of serious health consequences or death to humans and/or animals, then the FDA may
inspect the records related to that food.17 According to the FDA, such determinations are fact
(...continued)
Baking Mfg. Co., 345 F.Supp. 1371, 1376-77 (D. Del. 1972) (discussion whether FDA’s general inspection authority is
consistent with the Fourth Amendment).
10
21 U.S.C. §374(a)(1)(B).
11
See U.S. v. Gel Spice Co., Inc., 601 F.Supp. 1214, 1228-29 (E.D.N.Y. 1985).
12
21 U.S.C. §374(a)(1).
13
See FDA, Investigations Operations Manual 2014, Exhibit 5-1, Example of a Notice of Inspection,
http://www.fda.gov/downloads/ICECI/Inspections/IOM/ucm127428.pdf.
14
21 U.S.C. §374(b).
15
21 U.S.C. §374(c).
16
21 U.S.C. §331(f). See FDA, Investigations Operations Manual 2014, 5.2, http://www.fda.gov/ICECI/Inspections/
IOM/ucm122530.htm#5.2.5.1.
17
21 U.S.C. §350c(a).
Congressional Research Service
2
Food Recalls and Other FDA Administrative Enforcement Actions
specific, and thus are made on a case-by-case basis.18 The holder of the relevant records must
make the records accessible to the FDA within 24 hours from the receipt of the official FDA
request.19 The holders of these records include those who manufacture, process, pack, distribute,
receive, hold, or import the food.20 The FFDCA generally exempts farms, restaurants, and some
retail food establishments from these record requirements.21
Targeting Inspection Resources
FSMA directed the FDA to increase the frequency of inspections at all facilities.22 For domestic
high-risk facilities, the FDA must inspect each facility at least once between January 4, 2011,23
and January 4, 2016, and then once every three years after January 4, 2016. For domestic
facilities that are not high risk, the FDA must inspect each facility once between January 4, 2011,
and January 4, 2018, and then once every five years after January 4, 2018.
FSMA required the FDA to create “risk profiles” of certain foods susceptible to microbial
contamination in order to assist the FDA with scheduling inspections and allocating resources to
accommodate this increased frequency of food facility inspections.24 A risk profile incorporates
known safety risks of the food that is manufactured, processed, packed, or held at the facility.25
The profile also addresses the compliance history of the facility, and the effectiveness of the
facility’s hazard analysis and risk-based preventative controls.26
Fourth Amendment Constraints
Generally, government inspections are a form of a search, and thus are constrained by the Fourth
Amendment’s prohibition against “unreasonable searches and seizures.”27 However, courts have
held that the FDA is not required to obtain a search warrant to inspect a facility under Section 704
of the FFDCA as long as the FDA conducts the inspection reasonably as to time, place, and
method.28
In a case involving the inspection authority pursuant to the Gun Control Act of 1968,29 the U.S.
Supreme Court in U.S. v. Biswell stated that a warrantless inspection is reasonable under the
Fourth Amendment when a statute provides the authority to conduct an inspection in a carefully
limited manner.30 The Court expanded on this principle in New York v. Burger by holding that an
owner of commercial premises in a closely regulated industry has a reduced expectation of
privacy regarding inspections by the government. Therefore, according to the Court in Burger, a
18
79 Fed. Reg. 18799, 18801 (Apr. 4, 2014).
21 C.F.R. §1.361.
20
21 U.S.C. §350c(a).
21
21 C.F.R. §1.327.
22
FSMA, P.L. 111-353 (2011), §201.
23
FSMA’s date of enactment.
24
21 U.S.C. §350j(a).
25
Id.
26
Id.
27
U.S. CONST. amend. IV.
28
See, e.g., U.S. v. New England Grocers Supply Co., 488 F. Supp. 230, 238-39 (D. Mass. 1980).
29
18 U.S.C. §921 et seq.
30
U.S. v. Biswell, 406 U.S. 311, 315-16 (1972).
19
Congressional Research Service
3
Food Recalls and Other FDA Administrative Enforcement Actions
warrantless inspection of the commercial premises by the government may be reasonable under
the Fourth Amendment.31 The Court in this case outlined three criteria that would deem a
warrantless government inspection as reasonable under what the Court referred to as the
Colannade-Biswell doctrine.32 First, a substantial government interest must support the regulatory
inspection scheme.33 Second, the warrantless inspections must be “necessary to further [the]
regulatory scheme.”34 Finally, the regulatory statute must function as a warrant by limiting the
discretion of the inspecting officers and by advising the owner of the commercial premises that
the government may conduct a search within the properly defined scope of the law.35
Applying the Colannade-Biswell doctrine to FDA inspections, lower courts have concluded that
these inspections generally further a federal interest in food safety, and thus may proceed without
a warrant despite the potential threat to privacy.36 In U.S. v. New England Grocers Supply Co., the
court held that neither a warrant nor consent was required to inspect the defendant’s warehouse
because the government’s interest in food safety underlies the FDA’s inspection regulations and
the agency conducted the searches reasonably as to time, manner, and scope.37 Although
considering the search and seizure of veterinary drugs, the Ninth Circuit in U.S. v. Argent
Chemical Laboratories, Inc. held that an FDA inspection pursuant to the relevant FFDCA
provisions satisfied the Colannade-Biswell doctrine because a substantial government interest is
present regarding the safety and effectiveness of the product; unannounced, warrantless
inspections further the regulatory scheme by having a deterrent effect; and finally the FFDCA and
accompanying regulations define the scope of the search and serve as a “[C]onstitutionally
adequate substitute for a warrant.”38
Warning Letters
Section 309 of the FFDCA permits the FDA to decline to institute formal enforcement
proceedings for “minor violations of this [act] whenever [the agency] believes that the public
interest [would] be adequately served by a suitable written notice or warning.”39 These warning
letters give recipient firms an opportunity to take voluntary corrective actions before the FDA
initiates more formal enforcement action.40 A warning letter sent by the FDA also establishes
prior notice and documents prior warning if adequate corrections are not made and further
enforcement action is necessary.41
31
N.Y. v. Burger, 482 U.S. 691, 701-02 (1987).
Id. at 702-03.
33
Id. at 702.
34
Id. (citing Donovan v. Dewey, 452 U.S. 594, 600 (1981)).
35
Burger, 482 U.S. at 703.
36
See U.S. v. Bus. Builders, Inc., 354 F.Supp. 141, 143 (N.D. Okla. 1973); U.S. v. Del Campo Baking Mfg. Co., 345
F.Supp. 1371, 1376 (D. Del. 1972).
37
New England Grocers Supply Co., 488 F.Supp. at 238-39.
38
U.S. v. Argent Chem. Labs., Inc., 93 F.3d 572, 576 (9th Cir. 1996).
39
21 U.S.C. §336.
40
FDA, Regulatory Procedures Manual, 4-1-1, available at http://www.fda.gov/ICECI/ComplianceManuals/
RegulatoryProceduresManual/default.htm. It is important to note that the Regulatory Procedures Manual serves as a
reference for FDA employees and industry. The manual is not binding on industry or the agency.
41
Id.
32
Congressional Research Service
4
Food Recalls and Other FDA Administrative Enforcement Actions
The FDA may consider issuing a warning letter if the agency has found evidence that a firm or
product violates the FFDCA and that failure to correct such a violation may lead to the agency’s
consideration of further formal enforcement action.42 The agency may favor a warning letter as a
more efficient enforcement option if the agency reasonably expects that the responsible firm or
persons would take prompt corrective action after receiving such a letter.43
Warning letters include two types of correspondence: a regulatory letter and a report of
investigation finding.44 A regulatory letter warns the violator that formal enforcement is likely in
the absence of voluntary compliance. A report of investigation finding (also referred to as an
information letter) requests voluntary correction by the addressee. Both methods of
communication are informal and advisory.45 An FDA warning letter typically is labeled as such
and includes the dates of the inspection during which the agency discovered the statutory
violation(s).46 The letter would also request the recipient to institute corrective action(s) and to
return a written response to the agency’s warning letter. The FDA generally includes a warning in
the letter that failure to correct the violation promptly may result in additional enforcement
action.47
FDA warning letters are informal and advisory.48 A warning letter may communicate the FDA’s
position on a certain issue but does not commit the agency to taking any further enforcement
action. Thus, the FDA has concluded that a warning letter does not qualify as a final agency
action subject to judicial review under the Administrative Procedure Act.49
Courts generally agree with this interpretation of the legal status of warning letters. In Holistic
Candlers and Consumers Ass’n v. FDA, the D.C. Circuit found that the agency’s warning letters
requesting that the addressee take prompt action to correct certain FFDCA product violations did
not qualify as final agency action, and thus could not serve as the basis for the addressee’s legal
claim against the agency.50 The D.C. Circuit further articulated that in order for any agency action
to be “final” the action must mark the beginning of the agency’s decision-making process, and
that the action must be one from which “legal consequences will flow.”51 According to the court,
an FDA warning letter is not final because it provides firms with an opportunity to take voluntary
corrective action before the FDA decides to initiate any enforcement action.52 Additionally, the
court concluded that “legal consequences” cannot arise from warning letters due to their informal
and advisory nature.53 Similarly, the Ninth Circuit in Biotics Research Corp. v. Heckler
emphasized the point that FDA regulatory letters do not constitute final administrative
42
Regulatory Procedures Manual, supra note 40, at 4-1-3.
Id.
44
Regulatory Procedures Manual, supra note 40, at 4-1-1.
45
Id.
46
Regulatory Procedures Manual, supra note 40, at 4-1-10.
47
Id.
48
Regulatory Procedures Manual, supra note 40, at 4-1-1.
49
21 C.F.R. §10.65(a).
50
Holistic Candlers and Consumers Ass’n v. FDA, 664 F.3d 940, 946 (D.C. Cir. 2012).
51
Id. at 943.
52
Id. at 944.
53
Id.
43
Congressional Research Service
5
Food Recalls and Other FDA Administrative Enforcement Actions
determinations subject to judicial review due to the absence of any commitment on behalf of the
FDA to follow the correspondence with additional enforcement actions.54
Recalls
The recall process permits the FDA to enforce the adulteration and misbranding provisions of the
FFDCA by encouraging industry participants to remove the product and correct the violation.
This section addresses this FDA recall enforcement authority by first analyzing the various
triggers of the recall process and then by examining the FDA recall process itself. This section
concludes with an analysis of the due process concerns related to the mandatory recall
enforcement authority.
Types of Recalls
FDA regulations define a “recall” as a firm’s removal or correction of a marketed product that the
FDA considers to be in violation of the laws it administers and against which the agency would
initiate legal action, such as a seizure.55 Under these regulations, a “recall” is different from a
“market withdrawal.” A market withdrawal is a firm’s removal or correction of a distributed
product that involves a minor violation that would not be subject to legal action by the FDA.56 A
market withdrawal may not involve an FFDCA violation at all. Normal stock rotation practices
and routine equipment adjustments and repairs may prompt a market withdrawal.57 The FDA may
assist a firm issuing a market withdrawal when the cause for withdrawal may not be obvious or
clearly understood, but the deficiency of the product is apparent (for example, when a consumer
complains of adverse reactions to the product).58
A common reason for a recall is an undeclared ingredient.59 These recalls typically violate
FFDCA’s labeling provisions that require food labels to declare major food allergens.60 A food
label subject to such type of recall may not include a statement after the ingredient list disclosing
that the food contains a major food allergen, or the label may list the major food allergen in the
ingredients but not by the common or usual name. For example, Whole Foods Market recalled its
organic creamy spinach dip in December 11, 2013, because the label did not disclose that the dip
contained eggs, a major food allergen.61
Another common trigger of a recall is the detection of microbiological contamination, such as
Salmonella enteritidis and Listeria monocytogenes. For example, Flat Creek Farm & Dairy
recalled 200 pounds of Heavenly Blue Cheese in November 26, 2013, due to potential
contamination with Salmonella enteritidis.62 Recalls due to microbiological contamination often
54
Biotics Research Corp. v. Heckler, 710 F.2d 1375, 1377-78 (9th Cir. 1983).
55
21 C.F.R. §7.3(g).
56
21 C.F.R. §7.3(j).
57
Id.
58
21 C.F.R. §7.46(d).
59
Common food allergens include milk, egg, fish, shellfish, tree nuts, wheat, and peanuts. See FDA, 2013 Recalls,
Market Withdrawals & Safety Alerts, available at http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2013/default.htm.
60
See 21 U.S.C. §343(w).
61
Press Release, Whole Foods Market, Whole Foods Market Mid-Atlantic Region Recalls Spinach Dip Due to
Undeclared Egg (Dec. 11, 2013), available at http://www.fda.gov/Safety/Recalls/ucm378448.htm.
62
Press Release, Flat Creek Farm & Dairy, Flat Creek Farm & Dairy Recalls Heavenly Blue Because of Possible
Health Risk (Nov. 26, 2013), available at http://www.fda.gov/Safety/Recalls/ucm376981.htm.
Congressional Research Service
6
Food Recalls and Other FDA Administrative Enforcement Actions
arise because of a firm’s violation of the FDA’s Current Good Manufacturing Practices
(CGMPs).63 CGMPs outline the methods, equipment, facilities, and controls to produce safe and
wholesome food.
Voluntary and Mandatory Recalls
If the FDA determines that there is a reasonable probability that an article of food is adulterated64
or misbranded65 and the use or exposure to such article of food66 will cause serious health
consequences or death to humans or animals, the FDA then provides the responsible party with
the opportunity to cease distribution and recall such article of food voluntarily.67
While most recalls are “voluntary” or “requested by the FDA,” FSMA granted the FDA with the
authority to issue mandatory recalls.68 If the responsible party does not cease distribution or recall
such an article of food within the time and manner prescribed by the FDA or refuses to act at all,
the FDA may require the responsible party to immediately cease distribution of the violative
product.69 The FDA must provide the responsible party with the opportunity to initiate a voluntary
recall before the agency issues the mandatory recall order.70 After receiving the mandatory recall
order, the responsible party then notifies the following people of the recall: those involved in
manufacturing, processing, packing, transporting, distributing, receiving, holding, importing, or
selling of the product.71 The responsible party must also provide third-party warehouses with
sufficient information to identify the article of food covered by the recall.72
Recall Process
FDA guidance outlines five broad phases as part of the recall process for both voluntary and
mandatory recalls.73 The five phases are as follows: initiation, classification, notification,
monitoring, and termination.
Initiation of the Recall
The recalling firm and the FDA take different steps to initiate the recall depending on whether the
recall is voluntary, requested by the FDA, or mandated by the FDA. When a company voluntarily
initiates a recall, FDA regulations recommend that the recalling firm immediately contact the
63
See 21 C.F.R. §110.3 et seq.
21 U.S.C. §342.
65
21 U.S.C. §343.
66
The statute excludes infant formula from the articles of food that are subject to a voluntary recall under this
provision. 21 U.S.C. §350l(a). Infant formula recalls follow the procedures outlined in 21 C.F.R. §107.200 et seq.
67
21 U.S.C. §350l(a).
68
FSMA, P.L. 111-353 (2011), §206.
69
21 U.S.C. §350l(b)(1).
70
FDA cannot issue a mandatory recall for alcoholic beverages under the mandatory recall statutory authority (21
U.S.C. §350l) until the Alcohol and Tobacco Tax and Trade Bureau has had a reasonable opportunity to cease
distribution and recall such beverage. 21 U.S.C. §350l(e).
71
Id.
72
21 U.S.C. §350l(b)(2).
73
See generally, FDA, Regulatory Procedures Manual, Chapter 7, available at http://www.fda.gov/downloads/ICECI/
ComplianceManuals/RegulatoryProceduresManual/UCM074312.pdf.
64
Congressional Research Service
7
Food Recalls and Other FDA Administrative Enforcement Actions
FDA.74 At this phase, the recalling firm provides the FDA with the following information:
identity of the product involved in the recall; reason for removal; an evaluation of the risk; total
amount of such products produced and distributed; distribution information; and a proposed
strategy for conducting the recall.75
The FDA may request a recall if a product presents a risk of illness, injury, or gross consumer
deception; the firm has not initiated a recall of the product; and agency action is necessary to
protect public health and welfare.76 If the FDA has requested the recall, the FDA notifies the firm
that has the primary responsibility for the manufacture or marketing of the product of the need to
recall the product immediately.77 The firm then provides the agency with similar information to
that described in the above paragraph.78
If the FDA has issued a mandatory recall, the FDA then issues a written order to the firm to recall
the product.79 The order includes the provision of the act violated by the firm that prompted the
recall,80 the basis for FDA’s authority to issue the recall,81 a description of the product, and a time
frame for the firm to reply.82
Classification of the Recall
After either the FDA or the firm initiates the recall, the FDA evaluates the health hazard presented
by the product and looks at whether a precedent exists to guide strategy based on this specific
health hazard.83 Relying on the information from the evaluation, the FDA classifies the recall
according to the health hazard presented by the recalled product.84 A reasonable probability of
serious adverse health risks and/or death triggers a Class I recall.85 A Class II recall covers
products that may cause a temporary or medically reversible adverse health outcome.86 A Class III
recall includes violative products that are unlikely to cause an adverse health outcome. 87
When classifying a recall, an ad hoc committee of FDA scientists may take into account the
following factors:
“(1) Whether any disease or injuries have already occurred from the use of the product.
(2) Whether any existing conditions could contribute to a clinical situation that could
expose humans or animals to a health hazard....
74
21 C.F.R. §7.40(b).
21 C.F.R. §7.46(a).
76
21 C.F.R. §7.45(a)(1)-(3).
77
21 C.F.R. §7.45(b).
78
21 C.F.R. §7.45(c).
79
Regulatory Procedures Manual, supra note 40, at 7-5-3.
80
For example, the FDA will cite 21 U.S.C. §402 for adulterated food or 21 U.S.C §403(w) for misbranded food.
81
21 U.S.C. §350l.
82
Regulatory Procedures Manual, supra note 40, at 7-5-3.
83
Regulatory Procedures Manual, supra note 40, at 7-6-1.
84
21 C.F.R. §7.41
85
Id.
86
Id.
87
Id.
75
Congressional Research Service
8
Food Recalls and Other FDA Administrative Enforcement Actions
(3) Assessment of hazard to various segments of the population ... who are expected to be
exposed to the product being considered, with particular attention paid to the hazard to
those individuals who may be at greatest risk.
(4) Assessment of the degree of seriousness of the health hazard to which the populations
at risk would be exposed.
(5) Assessment of the likelihood of occurrence of the hazard.
(6) Assessment of the consequences (immediate or long-range) of occurrence of the
hazard.”
In conjunction with the classification, the FDA reviews the recall strategy presented by the firm.88
The strategy addresses the depth and scope of the recall, a communication plan to warn the
public, and methods used to measure the effectiveness of the recall.89
Notification and Public Warning
After classification, the firm must then notify affected parties. FDA regulations state that the
format, content, and extent of the recall communication should reflect the hazard of the product
being recalled as well as the strategy for that particular recall.90 Recall communications should
convey information that identifies the product in question and the reason for the recall and
provide instructions regarding any specific actions that should be taken with the product.91 FDA
guidance also outlines the scope of recipients. These recipients may include the wholesale
distributor, retail vendor, or the consumer, depending on how far the violative product has been
distributed in commerce.92
In addition to recall communications issued by the firm, the FDA also notifies other federal
agencies and state and local governments of the recall and relevant information.93 Additionally,
the FDA agency publicly discloses all recalls on its website, and may also notify consumers by
issuing a press release for Class I recalls.94 The FDA lists each recall and accompanying
information in its weekly FDA Enforcement Report.95 The agency does not include market
withdrawals or stock recoveries in this report.96
Monitoring and Auditing the Recall
The recalling firm has the legal responsibility to monitor the effectiveness of the recall.97 As part
of this monitoring, the firm must submit recall status reports to the appropriate FDA district
office, generally every two to four weeks.98 These reports update the agency on the number of
88
Regulatory Procedures Manual, supra note 40, at 7-6-3.
21 C.F.R. §7.42(b).
90
21 C.F.R. §7.49(a).
91
21 C.F.R. §7.49(a), (c).
92
See FDA, Guidance for Industry: Product Recalls, Including Removals and Corrections, Nov. 3, 2003, available at
http://www.fda.gov/Safety/Recalls/IndustryGuidance/ucm129259.htm.
93
Regulatory Procedures Manual, supra note 40, at 7-7-2.
94
Regulatory Procedures Manual, supra note 40, at 7-7-3.
95
21 C.F.R. §7.50.
96
Id.
97
Regulatory Procedures Manual, supra note 40, at 7-8-1.
98
21 C.F.R. §7.53(a).
89
Congressional Research Service
9
Food Recalls and Other FDA Administrative Enforcement Actions
individuals who were notified, the response to these notifications, and the number of products
returned.99 The FDA can provide assistance with monitoring the effectiveness of the recall if
some substantial difficulty is present, such as when the product is widely dispersed on the
consumer level.100 The FDA may also audit the recall independently of this assistance to ensure
that the recall action has been effective.101
Termination of the Recall
The FDA terminates a recall when the firm has completed all recall activity, as required by the
previous phases.102 When the FDA makes such a final determination, the agency provides a
written notification of the termination to the recalling firm. Generally, the agency officially
terminates a successful recall within three months of the recalling firm’s completion of the recall
activities.
Due Process Protections Within Mandatory Recall Authority
Before Congress granted the FDA with the mandatory recall authority under FSMA,
commentators speculating about the possibility of this method of enforcement raised concerns
about due process. Commentators were particularly concerned with the protection of a firm’s
interests against a potentially arbitrary mandatory recall order.103 FSMA’s provision mandating
that the FDA shall provide the responsible party subject to a mandatory recall order with the
opportunity for an informal hearing addresses these due process concerns.104
This informal hearing must occur no later than two days after the mandatory recall order.105 The
hearing is designed to address the actions required by the order. The recalling firm also has the
opportunity at the hearing to argue against the recall and to articulate reasons for its termination.
After the hearing, the FDA may then amend the order to specify a timetable for the recall and to
require periodic reports, submitted by the responsible party, updating the agency on the recall’s
progress; 106 or the agency may vacate the order if the agency determines at the hearing that
adequate grounds do not exist for the recall.107
Suspension of Registration
The FFDCA requires all food facilities to register with the FDA and to renew such registration
biennially so that the agency may effectively oversee all areas of food production.108 To register,
99
21 C.F.R. §7.53(b).
Regulatory Procedures Manual, supra note 40, at 7-8-1.
101
Regulatory Procedures Manual, supra note 40, at 7-8-2.
102
Regulatory Procedures Manual, supra note 40, at 7-9.
103
See, e.g., Julie Gallagher, “Recall Authority Would Allow for Due Process,” SUPERMARKET NEWS BLOG, (Apr. 20,
2009), http://supermarketnews.com/blog/recall-authority-would-allow-due-process; Michael T. Roberts, Mandatory
Recall Authority: A Sensible and Minimalist Approach to Improving Food Safety, 59 FOOD & DRUG L.J. 563, 579
(2004).
104
21 U.S.C. §350l(c); FSMA, P.L. 111-353 (2011), §206.
105
21 U.S.C. §350l(c).
106
21 U.S.C. §350l(d).
107
21 U.S.C. §350l(d)(2).
108
21 U.S.C. §350d(a).
100
Congressional Research Service
10
Food Recalls and Other FDA Administrative Enforcement Actions
facilities must submit the following information to the FDA: the name (including trade names),
address, and phone number of the facility, and the food product categories associated with that
facility.109 All food facilities that manufacture, process, pack, or hold food for consumption in the
United States must complete this registration process.110 However, FDA regulations exempt
foreign facilities, where the food from such facility undergoes further manufacturing or
processing by another facility outside the United States.111 Farms, retail food establishments,
restaurants, and meat and egg facilities that are regulated exclusively by the USDA are also
exempted from these requirements.112
The FFDCA113 authorizes the FDA to suspend the registration of a food facility to enforce the
public health and safety provisions of the act. If the FDA determines that a food manufactured,
processed, packed, received, or held by a facility has a reasonable probability of causing serious
adverse health consequences or death to humans or animals, the agency may suspend the
registration of a facility that created, caused, or was otherwise responsible.114 The agency may
also order a registration suspension of a facility that knew of or had reason to know of such
reasonable probability of harm and packed, received, or held such food.115 With its registration
suspended, a facility cannot import or export food into the United States or introduce food into
interstate or intrastate commerce in the United States.116 Any distribution of food products from
such facility violates the FFDCA and may lead to the FDA taking further enforcement action.117
Food facility registration and the suspension of such registration enable the agency to determine
the location and source of an outbreak of food-borne illnesses and thus notify facilities that may
be affected quickly and efficiently.118
Similar to other enforcement actions, the suspension provision in the FFDCA offers due process
protections for a facility subject to a registration suspension.119 The FDA must provide a
registrant with the opportunity for an informal hearing no less than two business days after
issuing a suspension order.120 The hearing gives the registrant an opportunity to present reasons
for reinstating the registration. If at the hearing, the FDA determines that a suspension is
necessary, the registrant must then submit a corrective action plan to the agency.121 The FDA will
reinstate a registration if the agency determines, based on the evidence presented at the hearing,
that adequate grounds do not exist to continue the suspension of the registration.122 When the
109
Id.
21 C.F.R. §1.225.
111
21 C.F.R. §1.226.
112
Id.
113
FSMA, P.L. 111-353 (2011), §102 amended §415 of the FFDCA to provide the FDA with the authority to suspend a
food facility’s registration.
114
21 U.S.C. §350d(b).
115
Id.
116
21 U.S.C. §350d(b)(4).
117
21 U.S.C. §331(d).
118
FDA, Guidance for Industry: What You Need to Know About Registration of Food Facilities, available at,
http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/ucm331957.htm.
119
See The Network for Public Health Law, “Section 102: Registration of Food Facilities,” FOOD SAFETY
MODERNIZATION ACT (FSMA) PRIMER, available at, https://www.networkforphl.org/_asset/d0v8kb/Primer-for-Section102-of-FSMA-FIN.pdf (briefly discusses the informal hearing opportunities in the context of due process protections).
120
21 U.S.C. §350d(b)(2).
121
21 U.S.C. §350d(b)(3).
122
21 U.S.C. §350d(b)(2).
110
Congressional Research Service
11
Food Recalls and Other FDA Administrative Enforcement Actions
FDA determines that adequate grounds do not exist to continue the suspension, the FDA will then
vacate the order suspending the facility’s registration and reinstate the registration for that
particular facility.123
Administrative Detention
Under Section 304 of the FFDCA,124 a designated FDA employee may order the detention of any
article of food that is found during an FDA inspection if the employee has reason to believe that
such article is adulterated or misbranded.125 Under this administrative detention authority, FDA
may prevent holders of illegal articles from moving the food before a federal district court issues
a warrant permitting the agency to seize the food.126 This enforcement authority also permits the
agency to prevent consumption of the illegal articles in an effort to ensure public safety. The FDA
may detain the food under an administrative detention for a reasonable period, generally
measured by the time necessary to institute a seizure action.127 The FFDCA states that such period
cannot exceed 30 days.128
Any person, who is entitled to claim the article, may file an appeal of the detention order.129 The
claimant must file the appeal within two calendar days upon receipt of the detention order for
perishable food and within four calendar days upon receipt of the detention order for
nonperishable food.130 Upon such appeal, the FDA must then grant the claimant the opportunity
for an informal hearing. At the informal hearing, the agency can either terminate or confirm the
order, which serves as a final agency action.131 Generally, federal courts lack jurisdiction over
agency actions committed under the agency’s discretion as granted by law, including, for
example, most of the statutory enforcement authorities discussed in this report.132 However, a
federal court may exercise judicial review of an agency’s activities, if such an activity is a final
agency action; the party subject to the agency action has exhausted the procedures provided by
the agency; and no other remedies at law are present.133 Therefore, the agency’s termination or
confirmation of an administrative detention order may be subject to judicial review.
123
Id.
FSMA, P.L. 111-353, §207 amended the FDA’s administrative detention authority under §304 of the FFDCA. Prior
to FSMA, the FDA could order an administrative detention if the agency had credible evidence that the food presented
a threat of serious adverse health consequences or death to humans or animals. See also FDA, FAQs on the Food Safety
Modernization Act, available at http://www.fda.gov/food/guidanceregulation/fsma/ucm247559.htm#registration.
125
21 U.S.C. §334(h)(1).
126
Regulatory Procedures Manual, supra note 40, at 5-3-2.
127
21 U.S.C. §334(h)(2).
128
Id.
129
21 U.S.C. §334(h)(4).
130
21 C.F.R. §1.402.
131
21 U.S.C. §334(h)(4).
132
See 5 U.S.C. §701(a).
133
5 U.S.C. §704.
124
Congressional Research Service
12
Food Recalls and Other FDA Administrative Enforcement Actions
Author Contact Information
(name redacted)
Legislative Attorney
Congressional Research Service
13
EveryCRSReport.com
The Congressional Research Service (CRS) is a federal legislative branch agency, housed inside the
Library of Congress, charged with providing the United States Congress non-partisan advice on
issues that may come before Congress.
EveryCRSReport.com republishes CRS reports that are available to all Congressional staff. The
reports are not classified, and Members of Congress routinely make individual reports available to
the public.
Prior to our republication, we redacted names, phone numbers and email addresses of analysts
who produced the reports. We also added this page to the report. We have not intentionally made
any other changes to any report published on EveryCRSReport.com.
CRS reports, as a work of the United States government, are not subject to copyright protection in
the United States. Any CRS report may be reproduced and distributed in its entirety without
permission from CRS. However, as a CRS report may include copyrighted images or material from a
third party, you may need to obtain permission of the copyright holder if you wish to copy or
otherwise use copyrighted material.
Information in a CRS report should not be relied upon for purposes other than public
understanding of information that has been provided by CRS to members of Congress in
connection with CRS' institutional role.
EveryCRSReport.com is not a government website and is not affiliated with CRS. We do not claim
copyright on any CRS report we have republished.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.